Cargando…
Correction to: A phase I, first-in-human study of TAK-164, an antibody–drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068635/ https://www.ncbi.nlm.nih.gov/pubmed/36967405 http://dx.doi.org/10.1007/s00280-023-04522-x |
| _version_ | 1785018701523714048 |
|---|---|
| author | Kim, Richard Leal, Alexis D. Parikh, Aparna Ryan, David P. Wang, Shining Bahamon, Brittany Gupta, Neeraj Moss, Aaron Pye, Joanna Miao, Harry Inguilizian, Haig Cleary, James M. |
| author_facet | Kim, Richard Leal, Alexis D. Parikh, Aparna Ryan, David P. Wang, Shining Bahamon, Brittany Gupta, Neeraj Moss, Aaron Pye, Joanna Miao, Harry Inguilizian, Haig Cleary, James M. |
| author_sort | Kim, Richard |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10068635 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100686352023-04-04 Correction to: A phase I, first-in-human study of TAK-164, an antibody–drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C Kim, Richard Leal, Alexis D. Parikh, Aparna Ryan, David P. Wang, Shining Bahamon, Brittany Gupta, Neeraj Moss, Aaron Pye, Joanna Miao, Harry Inguilizian, Haig Cleary, James M. Cancer Chemother Pharmacol Correction Springer Berlin Heidelberg 2023-03-26 2023 /pmc/articles/PMC10068635/ /pubmed/36967405 http://dx.doi.org/10.1007/s00280-023-04522-x Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Kim, Richard Leal, Alexis D. Parikh, Aparna Ryan, David P. Wang, Shining Bahamon, Brittany Gupta, Neeraj Moss, Aaron Pye, Joanna Miao, Harry Inguilizian, Haig Cleary, James M. Correction to: A phase I, first-in-human study of TAK-164, an antibody–drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C |
| title | Correction to: A phase I, first-in-human study of TAK-164, an antibody–drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C |
| title_full | Correction to: A phase I, first-in-human study of TAK-164, an antibody–drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C |
| title_fullStr | Correction to: A phase I, first-in-human study of TAK-164, an antibody–drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C |
| title_full_unstemmed | Correction to: A phase I, first-in-human study of TAK-164, an antibody–drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C |
| title_short | Correction to: A phase I, first-in-human study of TAK-164, an antibody–drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C |
| title_sort | correction to: a phase i, first-in-human study of tak-164, an antibody–drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase c |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068635/ https://www.ncbi.nlm.nih.gov/pubmed/36967405 http://dx.doi.org/10.1007/s00280-023-04522-x |
| work_keys_str_mv | AT kimrichard correctiontoaphaseifirstinhumanstudyoftak164anantibodydrugconjugateinpatientswithadvancedgastrointestinalcancersexpressingguanylylcyclasec AT lealalexisd correctiontoaphaseifirstinhumanstudyoftak164anantibodydrugconjugateinpatientswithadvancedgastrointestinalcancersexpressingguanylylcyclasec AT parikhaparna correctiontoaphaseifirstinhumanstudyoftak164anantibodydrugconjugateinpatientswithadvancedgastrointestinalcancersexpressingguanylylcyclasec AT ryandavidp correctiontoaphaseifirstinhumanstudyoftak164anantibodydrugconjugateinpatientswithadvancedgastrointestinalcancersexpressingguanylylcyclasec AT wangshining correctiontoaphaseifirstinhumanstudyoftak164anantibodydrugconjugateinpatientswithadvancedgastrointestinalcancersexpressingguanylylcyclasec AT bahamonbrittany correctiontoaphaseifirstinhumanstudyoftak164anantibodydrugconjugateinpatientswithadvancedgastrointestinalcancersexpressingguanylylcyclasec AT guptaneeraj correctiontoaphaseifirstinhumanstudyoftak164anantibodydrugconjugateinpatientswithadvancedgastrointestinalcancersexpressingguanylylcyclasec AT mossaaron correctiontoaphaseifirstinhumanstudyoftak164anantibodydrugconjugateinpatientswithadvancedgastrointestinalcancersexpressingguanylylcyclasec AT pyejoanna correctiontoaphaseifirstinhumanstudyoftak164anantibodydrugconjugateinpatientswithadvancedgastrointestinalcancersexpressingguanylylcyclasec AT miaoharry correctiontoaphaseifirstinhumanstudyoftak164anantibodydrugconjugateinpatientswithadvancedgastrointestinalcancersexpressingguanylylcyclasec AT inguilizianhaig correctiontoaphaseifirstinhumanstudyoftak164anantibodydrugconjugateinpatientswithadvancedgastrointestinalcancersexpressingguanylylcyclasec AT clearyjamesm correctiontoaphaseifirstinhumanstudyoftak164anantibodydrugconjugateinpatientswithadvancedgastrointestinalcancersexpressingguanylylcyclasec |